CA2294067C - Dispositif d'administration d'ingredients dermatologiques - Google Patents

Dispositif d'administration d'ingredients dermatologiques Download PDF

Info

Publication number
CA2294067C
CA2294067C CA002294067A CA2294067A CA2294067C CA 2294067 C CA2294067 C CA 2294067C CA 002294067 A CA002294067 A CA 002294067A CA 2294067 A CA2294067 A CA 2294067A CA 2294067 C CA2294067 C CA 2294067C
Authority
CA
Canada
Prior art keywords
skin
liquid
reservoir
shell
transfer pad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002294067A
Other languages
English (en)
Other versions
CA2294067A1 (fr
Inventor
Richard L. Devillez
Laura J. Crane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Consumer Care Holdings LLC
Original Assignee
Schering Plough Healthcare Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Healthcare Products Inc filed Critical Schering Plough Healthcare Products Inc
Publication of CA2294067A1 publication Critical patent/CA2294067A1/fr
Application granted granted Critical
Publication of CA2294067C publication Critical patent/CA2294067C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne un nouveau dispositif et un nouveau procédé d'administration d'un liquide renfermant un ingrédient actif à un site de traitement sur la peau. Le dispositif est utile pour le traitement de lésions ou aspects anormaux de la peau, tels que les cors, les verrues, les callosités, les oignons, les kératoses séniles et les peaux dures hyperkératosiques que l'on trouve souvent sur le visage, les bras, les jambes ou les pieds.
CA002294067A 1997-06-24 1997-06-24 Dispositif d'administration d'ingredients dermatologiques Expired - Lifetime CA2294067C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/011062 WO1998058631A1 (fr) 1997-06-24 1997-06-24 Dispositif d'administration d'ingredients dermatologiques

Publications (2)

Publication Number Publication Date
CA2294067A1 CA2294067A1 (fr) 1998-12-30
CA2294067C true CA2294067C (fr) 2005-11-15

Family

ID=22261154

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002294067A Expired - Lifetime CA2294067C (fr) 1997-06-24 1997-06-24 Dispositif d'administration d'ingredients dermatologiques

Country Status (4)

Country Link
EP (1) EP0991404A1 (fr)
AU (1) AU3791997A (fr)
CA (1) CA2294067C (fr)
WO (1) WO1998058631A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020172A1 (fr) * 2001-08-29 2003-03-13 De Carvalho Ricardo A P Systeme scellable et implantable destine a administrer des agents therapeutiques a des tissus de façon unidirectionnelle
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
JP6114841B2 (ja) 2013-02-28 2017-04-12 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． グリコピロレート塩
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US11607026B2 (en) 2014-05-30 2023-03-21 Johnson & Johnson Consumer Inc. Device for delivery of skin care composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4597961A (en) * 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
CA1280111C (fr) * 1985-04-03 1991-02-12 Richard E. Reever. Composition servant a administrer un medicament par voie transdermique
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
AU2514292A (en) * 1991-08-27 1993-03-16 Cygnus Therapeutic Systems Transdermal formulations for administering prazosin
US5460620A (en) * 1992-07-31 1995-10-24 Creative Products Resource, Inc. Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
AU5543196A (en) * 1995-04-12 1996-10-30 Robert B. Hopp Skin patch for use in contact immunotherapy

Also Published As

Publication number Publication date
AU3791997A (en) 1999-01-04
WO1998058631A1 (fr) 1998-12-30
EP0991404A1 (fr) 2000-04-12
CA2294067A1 (fr) 1998-12-30

Similar Documents

Publication Publication Date Title
US5962011A (en) Device for delivery of dermatological ingredients
AU2009233617B2 (en) Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US5230898A (en) Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof
US5641507A (en) Delivery system for dermatological and cosmetic ingredients
KR100406722B1 (ko) 수분흡수능이 우수한 매트릭스형 경피투여제
AU678237B2 (en) Active substance-containing plaster
US5861170A (en) Acetylsalicyclic acid-containing transdermal application system for antithrombotic therapy
PT697860E (pt) Sistema teraputico transdermico que contem estradiol
CA2294067C (fr) Dispositif d'administration d'ingredients dermatologiques
KR100663163B1 (ko) 비스테로이드성 소염진통제를 함유하는 경피 투여 제제
EP0297828A1 (fr) Pansements traitants avec médicaments
CA2338859A1 (fr) Emplatre contenant de l'estradiol pour l'administration transdermique d'hormones
CA2335582A1 (fr) Systeme therapeutique transdermique, contenant des hormones et des inhibiteurs de cristallisation
JP2002521427A5 (fr)
JP4938949B2 (ja) アセチルサリチル酸および／またはサリチル酸投与用の経皮治療システム
JP2001104359A (ja) 冷却シート
WO1993023019A1 (fr) Dispositifs d'apport medicamenteux transcutane, compositions qui y sont associees et procedes d'utilisation
AU584025B2 (en) Bandage for sustained delivery of drugs
CA2150033A1 (fr) Systeme d'administration transdermique contenant de l'acide acetylsalicylique pour therapie antiplaquettaire et prevention du cancer
US5965155A (en) Transdermal therapeutic system with pentylene tetrazol as active substance
JP2540861B2 (ja) 湿布剤
JP2001039873A (ja) 経皮吸収型排尿障害治療剤
KR100272043B1 (ko) 알쯔하이머성 치매치료용 경피흡수제제
KR20080006960A (ko) 소수성 비스테로이드성 소염진통제를 함유하는 경피 투여제제

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170627